Dividend andome Fund (Dividend andome Fund) Growth Rank : 0 (As of May. 11, 2024)

View and export this data going back to . Start your Free Trial

What is Dividend andome Fund Growth Rank?

Dividend andome Fund has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Dividend andome Fund Growth Rank Related Terms

Thank you for viewing the detailed overview of Dividend andome Fund's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Dividend andome Fund (Dividend andome Fund) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Dividend and Income Fund (OTCPK:BXSY) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

3814 Route 44, Millbrook, New York, NY, USA, 12545

Website

https://www.dividendandincomefund.com

Dividend and Income Fund is a closed-ended management investment company. The fund's investment objective is to seek high current income with a secondary objective of capital appreciation. The fund seeks to invest in stocks of companies operating across diversified sectors. It mainly invests in dividend-paying stocks of companies across all capitalizations. The Fund seeks to achieve its objectives by investing, under normal circumstances, in income-generating equity securities, including dividend-paying common stocks, convertible securities, preferred stocks, securities of registered investment companies, exchange-traded funds organized as investment companies or otherwise, real estate investment trusts, depositary receipts, and other equity-related securities.

Executives

Thomas Bassett Winmill	director, officer: President	P.O. BOX 4, WALPOLE NH 03608
Peter K Werner	director	2255 BUFFALO ROAD, ROCHESTER NY 14624
Bexil Corp	other: See "Explanation of Responses"	2255 BUFFALO ROAD, ROCHESTER NY 14624
Roger A. Atkinson	director	9202 NW 28TH COURT, VANCOUVER WA 98665
Bexil Advisers Llc	other: See "Explanation of Responses"	2255 BUFFALO ROAD, ROCHESTER NY 14624
Bexil Securities Llc	other: See "Explanation of Responses"	3814 ROUTE 44, MILLBROOK NY 12545
Donald Ii Klimoski	officer: Assistant General Counsel	3814 ROUTE 44, MILLBROOK NY 12545
William Mccollum Winmill	officer: VP and Co-Portfolio Manager	11 HANOVER SQUARE, 12TH FLOOR, NEW YORK NY 10005
Jon Tomasson	director	11 HANOVER SQUARE, 12TH FLOOR, NEW YORK NY 10005
Russell Kamerman	officer: Chief Compliance Officer	3814 ROUTE 44, MILLBROOK NY 12545
Hwang Eric Paul C.	other: See "Explanation of Responses"	11 HANOVER SQUARE, NEW YORK NY 10005
Castle Mortgage Corp	other: See "Explanation of Responses"	701 MONTGOMERY HWY SOUTH, STE. 203, VESTAVIA HILLS AL 35216
Jacob Bukhsbaum	officer: Chief Compliance Officer, other: See "Explanation of Responses"	11 HANOVER SQUARE, NEW YORK NY 10005
Bexil American Mortgage Inc.	other: See "Explanation of Responses"	11 HANOVER SQUARE, NEW YORK NY 10005
Midas Management Corp	other: See "Explanation of Responses"	11 HANOVER SQUARE, NEW YORK NY 10005